People: Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

19 Jul 2019
Change (% chg)

$-0.29 (-2.87%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Campoy, Carlos 

Mr. Carlos Campoy is Chief Financial Officer of the Company. Mr. Campoy has served as our Chief Financial Officer since December 2018. From September 2017 to December 2018, Mr. Campoy served as a partner of Think Forwards, a financial consulting firm. From March 2015 to November 2016, Mr. Campoy served as Vice President of Finance, International at Allergan plc, where he previously served as Vice President and Financial Controller, Europe, Africa and Middle East from July 2014 to March 2015. Prior to joining Allergan, Mr. Campoy had an 18-year tenure at Eli Lilly and Company, from August 1996 to July 2014, where he held a number of senior financial leadership positions of increasing responsibility, most recently serving as Chief Financial Officer, Eli Lilly Japan K.K. from January 2013 to July 2014. Mr. Campoy is a Certified Management Accountant (CMA). He holds an M.B.A. in Finance and Decision Information Systems from Indiana University and a B.S. in Management from Faculdade C.C. Administracao de Tupa, Tupa in São Paulo, Brazil.

Basic Compensation

Total Annual Compensation, USD 22,077
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,822,300
Fiscal Year Total, USD 1,844,370

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Azelby


Carlos Campoy


Erin Lavelle


James Bucher


Randal Hassler


Nadia Dac

As Of  31 Dec 2018